PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy

Category: Press release

PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy

PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy

Roden — November 20, 2020 — PureIMS, a clinical stage pharmaceutical and medication systems company focused on developing and commercializing innovative inhaled therapies for systemic and respiratory diseases has appointed Bram van Dijck to the role of Chief Executive Officer (CEO) with immediate effect. Mr. van Dijck joins PureIMS from the Grünenthal Group where he […]

PureIMS Initiates Phase 1 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of Amikacin for Early Eradication Treatment of Tuberculosis

PureIMS Initiates Phase 1 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of Amikacin for Early Eradication Treatment of Tuberculosis

Delivery via inhaler could dramatically expand Amikacin’s clinical utility by immediate reduction of the contagiousness of Mycobacterium tuberculosis. Roden — July 1st, 2020 — PureIMS, a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory and systemic diseases, announces today the initiation of a Phase 1 clinical trial to evaluate the […]

Hydroxychloroquine Cyclops in Dutch pharmacy magazine ‘Pharmaceutisch Weekblad’

Hydroxychloroquine Cyclops in Dutch pharmacy magazine ‘Pharmaceutisch Weekblad’

In the fight against COVID-19, PIMS Hydroxychloroquine (subsidiary of PureIMS) – together with (among others) the University of Groningen, UMCG and IMDS – is working feverishly on inhaled hydroxychloroquine. Following pulmonary administration, we expect a much greater effect of the drug with a lower chance of side effects, because it is administered directly to the […]

PureIMS joins the battle against Coronavirus (COVID-19)

PureIMS joins the battle against Coronavirus (COVID-19)

In a joint effort with UMCG, University of Groningen and several international partners, PureIMS is actively battling the COVID-19 pandemic by repurposing hydroxychloroquine for pulmonary administration. A first in man trial with Hydroxychloroquine Cyclops™ is in preparation. Nevertheless, it will take months if not longer before this product will become available, if proven effective. We are […]

Cyclops as example of the TopDutch pioneering and collaborating mentality

Cyclops as example of the TopDutch pioneering and collaborating mentality

The Cyclops™ pre-loaded disposable dry powder inhaler is a product of TopDutch’s life science & health industry and mentioned as an example of the TopDutch pioneering and collaborating mentality! More info